Eris Lifesciences Limited ERIS.BO Stock
Eris Lifesciences Limited Price Chart
Eris Lifesciences Limited ERIS.BO Financial and Trading Overview
| Eris Lifesciences Limited stock price | 844.85 INR |
| Previous Close | 654.25 INR |
| Open | 655 INR |
| Bid | 658.4 INR x 0 |
| Ask | 659.85 INR x 0 |
| Day's Range | 652 - 662.5 INR |
| 52 Week Range | 550.9 - 749.85 INR |
| Volume | 1.46K INR |
| Avg. Volume | 2.71K INR |
| Market Cap | 90.8B INR |
| Beta (5Y Monthly) | 0.352739 |
| PE Ratio (TTM) | 23.794724 |
| EPS (TTM) | 28.34 INR |
| Forward Dividend & Yield | 14.7 (2.22%) |
| Ex-Dividend Date | August 11, 2022 |
| 1y Target Est | 789.6 INR |
ERIS.BO Valuation Measures
| Enterprise Value | 97.4B INR |
| Trailing P/E | 23.794724 |
| Forward P/E | 22.540228 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.4637403 |
| Price/Book (mrq) | 4.077664 |
| Enterprise Value/Revenue | 5.861 |
| Enterprise Value/EBITDA | 18.147 |
Trading Information
Eris Lifesciences Limited Stock Price History
| Beta (5Y Monthly) | 0.352739 |
| 52-Week Change | 5.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 749.85 INR |
| 52 Week Low | 550.9 INR |
| 50-Day Moving Average | 622.96 INR |
| 200-Day Moving Average | 655 INR |
ERIS.BO Share Statistics
| Avg. Volume (3 month) | 2.71K INR |
| Avg. Daily Volume (10-Days) | 3.08K INR |
| Shares Outstanding | 135.99M |
| Float | 37.92M |
| Short Ratio | N/A |
| % Held by Insiders | 79.01% |
| % Held by Institutions | 15.19% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 7.35 |
| Trailing Annual Dividend Yield | 1.12% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2618 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 22.99% |
| Operating Margin (ttm) | 25.25% |
| Gross Margin | 78.79% |
| EBITDA Margin | 32.29% |
Management Effectiveness
| Return on Assets (ttm) | 8.83% |
| Return on Equity (ttm) | 18.12% |
Income Statement
| Revenue (ttm) | 16.62B INR |
| Revenue Per Share (ttm) | 122.19 INR |
| Quarterly Revenue Growth (yoy) | 31.69% |
| Gross Profit (ttm) | 13.44B INR |
| EBITDA | 5.37B INR |
| Net Income Avi to Common (ttm) | 3.82B INR |
| Diluted EPS (ttm) | 27.67 |
| Quarterly Earnings Growth (yoy) | -18.50% |
Balance Sheet
| Total Cash (mrq) | 892.43M INR |
| Total Cash Per Share (mrq) | 6.56 INR |
| Total Debt (mrq) | 9.07B INR |
| Total Debt/Equity (mrq) | 40.84 INR |
| Current Ratio (mrq) | 1.725 |
| Book Value Per Share (mrq) | 161.465 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.92B INR |
| Levered Free Cash Flow (ttm) | -7022927360 INR |
Profile of Eris Lifesciences Limited
| Country | India |
| State | N/A |
| City | Ahmedabad |
| Address | Shivarth Ambit |
| ZIP | 380054 |
| Phone | 91 79 6966 1000 |
| Website | https://www.eris.co.in |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
Q&A For Eris Lifesciences Limited Stock
What is a current ERIS.BO stock price?
Eris Lifesciences Limited ERIS.BO stock price today per share is 844.85 INR.
How to purchase Eris Lifesciences Limited stock?
You can buy ERIS.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eris Lifesciences Limited?
The stock symbol or ticker of Eris Lifesciences Limited is ERIS.BO.
Which industry does the Eris Lifesciences Limited company belong to?
The Eris Lifesciences Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Eris Lifesciences Limited have in circulation?
The max supply of Eris Lifesciences Limited shares is 136.05M.
What is Eris Lifesciences Limited Price to Earnings Ratio (PE Ratio)?
Eris Lifesciences Limited PE Ratio is 29.81122000 now.
What was Eris Lifesciences Limited earnings per share over the trailing 12 months (TTM)?
Eris Lifesciences Limited EPS is 28.34 INR over the trailing 12 months.
Which sector does the Eris Lifesciences Limited company belong to?
The Eris Lifesciences Limited sector is Healthcare.